Thanks ATL for sharing your info about the Dr Liau profound reality. With Dr Duffy camped out at NWBO for a few months It's very likely Merck is intimately aware the enormous possibilities of DC Vax treating many cancers.
FDA BLA Acceptance PR....and "all heel breaks loose".....$20 to $200 PPS....PRECISELY
“About time for precision immunotherapy”. As an MRK / BMY shareholder I’ve stated I would expect both to exhaust all non-autologous alternatives for CI combos before embarking the autologous combination route ……CI targeting has been somewhat scattered to date. Perhaps it’s about time to dial in a little more precision in targeting???
Dr. Linda Liau also made the following statement, which is very reassuring and validating:
”We have done many different trials over the years, pulsing these cells with tumor peptides, RNA, DNA, and all sorts of things, but quite frankly, the actual tumor Lysates were best“